Clinical Trial

Clamp Study to Estimate the Relative Potency of GZR33 Versus Insulin Degludec at Steady State

Recruiting Phase 1
View on ClinicalTrials.gov →
Record status
This record was last updated November 21, 2025 (before its estimated February 28, 2026 completion). Its status may not reflect the trial's current state.
Summary
This trial intends to investigate the pharmacodynamics, pharmacokinetics, safety, and tolerability of insulin GZR33 (hereafter referred to as GZR33) and estimate its potency in comparison with insulin degludec.
Trial Details
NCT Number NCT07242664
Lead Sponsor Gan and Lee Pharmaceuticals, USA
Conditions Type 1 Diabetes Mellitis
Enrollment 12 participants
Start Date 2025-10-13
Primary Completion 2026-02-28 (estimated)
Study Completion 2026-04-15 (estimated)
Updated on ClinicalTrials.gov 2025-11-21